CONSUMER NEWS    RECALLS    COMPLAINT FORM    SCAM ALERTS  


Complain about a product or service

Small Claims Guide | Class Actions | Lemon Law | FAQ | Resources | Newsletters | Spanish
Automotive    Education    Electronics    Family    Finance    Health    Homeowners    Shopping    Travel   
NEWS   Latest |  Archives |  Auto |  Cells, etc. |  Computers |  Financial |  Health |  Homeowners |  Parents |  Privacy |  Scams |  Seniors |  Travel

Study: PSA Test Doesn't Improve Prostate Cancer Survival Rate





January 9, 2006


Broccoli Reduces Prostate Cancer Risk, Study Finds
Celebrex-Lipitor Combo May Halt Prostate Cancer
Exercise May Speed Prostate Tumor Growth
Soy Compound May Halt Spread of Prostate Cancer
Obesity Linked to Higher Prostate Cancer Mortality
Red Wine May Fight Prostate Cancer
Enlarged Prostate Doesn't Mean Cancer
Hopkins Researchers Claim Better Blood Test for Prostate Cancer
Severe Form of Enlarged Prostate Disease Discovered
Tomato-Broccoli Combo Can Help Shrink Prostate Cancers
Weight Gain Increases Risk of Dying from Prostate Cancer
Smoking Linked to Complications in Prostate Cancer Treatment
Newer Approach Urged in Screening for Aggressive Prostate Cancer
Aspirin May Prevent or Delay Enlarged Prostate
Hopkins Researchers Find Better Blood Test for Prostate Cancer
Prostate Radiation May Cause Problems Later
New Test Detects Prostate Cancer Spread Earlier
Castration May Be Advised in Advanced Prostate Cancer
Radiation Therapy May Be Best for Younger Prostate Cancer Patients
Study Recommends More Prostate Biopsies
Delayed Surgery May Be OK for Some Prostate Cancer Patients
Study: PSA Test Doesn't Improve Prostate Cancer Survival Rate
Prostate Cancer Genes Identified
Annual Prostate Cancer Screening Test Appears to Save Lives
FDA Panel Rejects Prostate Cancer Pill
PSA Test Still Useful, Hopkins Study Finds
No "Normal" PSA Level: Study
New Prostate Cancer Test Shows Promise
Lifestyle and Diet May Stop or Reverse Prostate Cancer Progression

A screening test for prostate cancer that measures prostate-specific antigen (PSA) levels does not improve survival, researchers at the Veterans Affairs (VA) Connecticut Healthcare System and Yale School of Medicine report in the January 9 Archives of Internal Medicine.

Prostate cancer is the most common cancer affecting American men and ranks second in mortality. According to the study, screening tests almost always increase the detection of cancer, but among other requirements for improving survival, the tumors detected must be both fatal (if left untreated) yet curable.

PSA, a protein produced in the prostate, is found in the blood of healthy men. Prostate cancer often increases PSA levels in the blood, but a similar increase can be caused by benign enlargement of the prostate gland (prostatism) or prostate infections.

To test the impact of prostate cancer screening on survival, the researchers conducted a case-control review of the medical records of over 1,000 male veterans age 50 or older receiving care at 10 VA medical centers in New England.

Half of the men had died with prostate cancer; the other half were living and matched to be the same age as those who died. The study included up to nine years of follow-up after the diagnosis of cancer. The researchers compared the group that died with the group that lived and found that the same fraction of men had received screening with the PSA test.

"This study suggests that screening was not effective," said first author John Concato, M.D., associate professor of medicine at Yale School of Medicine and director of the Clinical Epidemiology Research Center at the VA Connecticut Healthcare System. "If screening worked, men who died would have had less testing than those who lived."

Concato and his team also determined that digital rectal examinations along with PSA did not improve survival.

"Unfortunately, screening tests can sometimes find cancer, even at early stages, but not prolong survival," said Concato, who is also a member of the Yale Cancer Center. "Rather than encouraging annual screening of all men starting at age 50, as is commonly done, the limited effectiveness of PSA testing should be explained to patients in the process of obtaining their informed consent to the test."



Report Your Experience
If you've had a bad experience -- or a good one -- with a consumer product or service, we'd like to hear about it. All complaints are reviewed by class action attorneys and are considered for publication on our site. Knowledge is power! Help spread the word. File your consumer report now.


Consumer News

July 23 2008

Recent Recalls & Safety Alerts

Print, mail, etc.






FREE CONSUMER NEWSLETTERS

The Daily Consumer
Afternoons M-F

Sign up now!


Consumer News & Alerts
Every Sunday

Sign up now!


Knowledge is free.
Knowledge is power.



Back to the top |

Advertisement


Home | Rogues Gallery | Good Guys | Complaint Form | News | Recalls | Search | Video | FAQ |
Consumer Resources | Small Claims Guide | Lemon Law | Newsletter | Contact Us
Advertise With Us | Testimonials | Newsroom | RSS Feeds | Radio | Job Postings




Terms of Use Your use of this site constitutes acceptance of the Terms of Use

Advertisements on this site are placed and controlled by outside advertising networks. ConsumerAffairs.com does not evaluate or endorse the products and services advertised. See the FAQ for more information.

Company Response Welcome If complaints about your company appear on our site, we welcome your response. Please see the Response Form for more information.

For more information, see the FAQ and privacy policy. The information on this Web site is general in nature and is not intended as a substitute for competent legal advice.  ConsumerAffairs.com Inc. makes no representation as to the accuracy of the information herein provided and assumes no liability for any damages or loss arising from the use thereof. 

Copyright © 2003-2008 ConsumerAffairs.com Inc.  All Rights Reserved.